In a small, early comparison, a novel repositionable valve yields greater device success than a self-expanding valve in high-risk TAVR patients, according to a paper published in the June 2015 issue ...
PARIS, France—One-year results for the first, large, international head-to-head trial comparing two competitive transcatheter aortic valves demonstrate that the Lotus Valve System (Boston Scientific) ...